Nöroimmünolojik Hastalıklarda Görüntüleme Bulguları

Amytice Mirchi, Sarah Hopkins. Pediatric acquired demyelinating syndromes: updates in diagnosis, testing, and management Curr Opin Pediatr. 2024 Dec 1;36(6):644-652. doi: 10.1097/MOP.0000000000001405.

Serena Massa, Adriana Fracchiolla, Cosimo Neglia, Alberto Argentiero, Susanna Esposito. Update on Acute Disseminated Encephalomyelitis in Children and AdolescentsChildren (Basel). 2021 Apr 6;8(4):280. doi: 10.3390/children8040280.

Garrick Biddle, Ryan T Beck, Osama Raslan, Julius Ebinu, Zach Jenner , John Hamer , Lotfi Hacein-Bey , Michelle Apperson , Vladimir Ivanovic Autoimmune diseases of the spine and spinal cord Neuroradiol J. 2024 Jun;37(3):285-303. doi: 10.1177/19714009231187340.

Sven Jarius, Orhan Aktas, Ilya Ayzenberg, et al. Neuromyelitis Optica Study Group (NEMOS) Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis J Neurol. 2023 Jul;270(7):3341-3368. doi: 10.1007/s00415-023-11634-0.

Wingerchuk DM, Banwell B, Bennett JL, et al. International Panel for NMOD (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177–189

Kelsey A Stefan, John R Ciotti MOG Antibody Disease: Nuances in Presentation, Diagnosis, and Management Curr Neurol Neurosci Rep. 2024 Aug;24(8):219-232. doi: 10.1007/s11910-024-01344-z.

Arius, S., Ruprecht, K., Kleiter, I., et al. (2016). MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J. Neuroinflamm. 13:280. doi: 10.1186/s12974-016-0718-0

Sato, D. K., Callegaro, D., Lana-Peixoto, M. A.,et al. 2014. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82, 474–481.

Yunjie Li, Xia Liu, Jingxuan Wang, et al. Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD) Front Aging Neurosci. 2022 Mar 15:14:850743. doi: 10.3389/fnagi.2022.850743.

Kitley, J., Waters, P., Woodhall, M. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 71, 276–283. doi: 10.1001/jamaneurol.2013.5857

Bruijstens AL, Lechner C, Berliac LF, et al. E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Review Eur J Paediatr Neurol. 2020 Nov;29:2-13.

Filippi M, Rocca MA, Ciccarelli O, et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 2016; 15: 292-303.

Filippi M, Preziosa P, Banwell BL, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain 2019; 142: 1858-1875.